SEC Form 4 · accession 0001209191-17-017986
PURE BIOSCIENCE, INC. · PURE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
William Otis
Director
Period of report
Mar 1, 2017
Accepted (ET)
Mar 3, 2017 · 6:26 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001006028
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $0.88 | Mar 1, 2017 | A | 100,000 | A | — | Mar 1, 2022 | Common Stock | 100,000 | 100,000 | D |
Explanation of responses
- F1The option shares shall vest and become exercisable in four equal installments on April 30, 2017, July 31, 2017, October 31, 2017 and January 31, 2018.